Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with Wegovy Warnings and Precautions Risk of Thyroid C-Cell Tumors : Patients should be further evaluated if serum calcitonin is measured and found to be elevated or thyroid nodules are noted on physical examination or neck imaging Acute Pancreatitis : Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including Wegovy
These developments offer individuals seeking weight loss programs alternatives that work with the body's natural mechanisms rather than against them
It's crucial to maintain at least 48 hours between doses for safety
But Jay Campbell, founder of BioLongevity Labs, a manufacturer of research-grade peptides, remains skeptical that the outcome is a real positive for peptide access
If anything, we think of this company as like, oh, it's the GLP-1 company, it's the weight loss drug company